Mauritania vs Serbia: Access to anti-retroviral drugs, female
Mauritania
68.0%
in 2024
Serbia
69.0%
in 2024
Mauritania rank
86th
Serbia rank
84th
Access to anti-retroviral drugs, female over time
- Mauritania
- Serbia
How they compare
Serbia currently reports 69.0% against 68.0% in Mauritania, a difference of 1.0%.
Across all 25 years both countries report, Serbia has been ahead every year.
Mauritania ranks 86th and Serbia ranks 84th of 141 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritania | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 23.9% | 18.3% | Serbia |
| 2010s | 35.7% | 60.4% | 24.7% | Serbia |
| 2020s | 60.4% | 70.0% | 9.6% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Mauritania or Serbia?
- Serbia, at 69.0% against 68.0% in Mauritania as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Mauritania and Serbia?
- 1.0%, with Serbia ahead.
- How many years of comparable data are there for Mauritania and Serbia?
- 25 years are reported by both, from 2000 to 2024.
- How do Mauritania and Serbia rank globally for access to anti-retroviral drugs, female?
- Mauritania ranks 86th and Serbia ranks 84th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.